GlassScriptPhysician profile
Judith A Scott
NPI 1003959024
$2,719.47
in general payments reported to CMS, 2019-2025
34 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $61.15 · 2021: $361 · 2022: $511 · 2023: $533 · 2024: $551 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.80 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $435.66 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $331.99 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $283.16 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.45 | 2019-2025 | |
| Daiichi Sankyo INC. | $160.97 | 2019-2024 | Injectafer |
| Exeltis, USA INC. | $156.89 | 2021-2025 | Slynd, Tyblume |
| Gilead Sciences, INC. | $140.25 | 2024 | Epclusa |
| Hologic Sales and Service, LLC | $127.95 | 2021-2024 | Omni Hysteroscope, Acessa Provu System, Coolseal Generator |
| Biogen, INC. | $100.99 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $86.43 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $69.35 | 2019-2023 | Gardasil 9 |
| Amag Pharmaceuticals, INC. | $57.92 | 2019 | |
| Organon LLC | $53.84 | 2022-2024 | |
| Allergan, INC. | $49.01 | 2019 | |
| Therapeuticsmd, INC. | $36.75 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $34.70 | 2022 | |
| Myovant Sciences INC. | $34.47 | 2022 | |
| Olympus America INC. | $34.26 | 2023-2024 | Olympus, Olympus |
| Sanofi Pasteur INC. | $31.28 | 2024 | |
| Conmed Corporation | $28.87 | 2025 | Airseal |
| Duchesnay USA Incorporated | $28.67 | 2019 | |
| Meditrina | $26.26 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $25.43 | 2021 | |
| Pfizer INC. | $25.10 | 2021-2022 | |
| Karl Storz Endoscopy-America | $24.70 | 2020 | |
| Medicem INC. | $22.68 | 2024 | |
| Agile Therapeutics, INC. | $19.73 | 2021 | |
| Baxter Healthcare | $19.69 | 2023 | Floseal |
| Amgen INC. | $16.82 | 2025 | Evenity |
| Roche Diagnostics Corporation | $15.83 | 2019 | |
| Coopersurgical, INC. | $14.22 | 2023 | Paragard T 380a |
| Mallinckrodt Enterprises LLC | $13.50 | 2019 | |
| Exact Sciences Corporation | $13.30 | 2023 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.